Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.

JACC. Cardiovascular Imaging
Timothy J PoteruchaMathew S Maurer

Abstract

This study aimed to characterize trends in technetium Tc 99m pyrophosphate (99mTc-PYP) scanning for amyloid transthyretin cardiac amyloidosis (ATTR-CA) diagnosis, to determine whether patients underwent appropriate assessment with monoclonal protein and genetic testing, to evaluate use of single-photon emission computed tomography (SPECT) in addition to planar imaging, and to identify predictive factors for ATTR-CA. 99mTc-PYP scintigraphy has been repurposed for noninvasive diagnosis of ATTR-CA. Increasing use of 99mTc-PYP can facilitate identification of ATTR-CA, but appropriate use is critical for accurate diagnosis in an era of high-cost targeted therapeutics. Patients undergoing 99mTc-PYP scanning 1 h after injection at a quaternary care center from 2010 to 2019 were analyzed; clinical information was abstracted; and SPECT results were analyzed. Over the decade, endomyocardial biopsy rates remained stable with scanning rates peaking at 132 in 2019 (p < 0.001). Among 753 patients (516 men, mean age 77 years), 307 (41%) had a visual score of 0, 177 (23%) of 1, and 269 (36%) of 2 or 3. Of 751 patients with analyzable heart to contralateral chest ratios, 249 (33%) had a ratio ≥1.5. Monoclonal protein testing status was assessed...Continue Reading

References

Oct 26, 1978·The New England Journal of Medicine·D F Ransohoff, A R Feinstein
Sep 1, 1983·The New England Journal of Medicine·A RozanskiH J Swan
Aug 1, 2015·European Heart Journal·Esther González-LópezPablo Garcia-Pavia
Oct 27, 2015·Advances in Therapy·Isabelle LousadaGiampaolo Merlini
Jan 7, 2016·Current Opinion in Neurology·David AdamsUNKNOWN from the European Network for TTR-FAP (ATTReuNET)
May 5, 2016·Circulation·Julian D GillmorePhilip N Hawkins
Sep 2, 2016·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Sabahat BokhariMathew S Maurer
Sep 14, 2016·Circulation. Heart Failure·Jason N DunguLisa J Anderson
Mar 24, 2018·Journal of Cardiac Failure·Ray E HershbergerStephanie M Ware
Jun 16, 2018·International Journal of Cardiology·Laroussi Mohamed-SalemDomingo A Pascual-Figal
Jun 16, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Ray E HershbergerUNKNOWN ACMG Professional Practice and Guidelines Committee
Sep 1, 2018·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Eve BishopMarc K Halushka
Oct 20, 2018·Journal of the American College of Cardiology·Brett W SperryMazen Hanna
Jan 11, 2019·The New England Journal of Medicine·Christopher Manion, Umesh C Sharma
May 22, 2019·Circulation·Thirusha LaneJulian D Gillmore
Jun 7, 2019·Journal of the American College of Cardiology·Frederick L RubergMathew S Maurer
Dec 23, 2019·JACC. Cardiovascular Imaging·Maria Beatrice MusumeciClaudio Rapezzi
May 18, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Brett W SperryTimothy M Bateman
Jun 2, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Claudine RégisMatthieu Pelletier-Galarneau

❮ Previous
Next ❯

Citations

May 24, 2021·JACC. Cardiovascular Imaging·Timothy J PoteruchaMathew S Maurer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.